H Lundbeck Net Worth 2011-2021 | HLUYY

Interactive chart of historical net worth (market cap) for H Lundbeck (HLUYY) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. H Lundbeck net worth as of September 17, 2021 is $5.38B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $5.383B $2.707B
H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of pharmaceuticals across the world. Its products are targeted at disorders like depression and anxiety, schizophrenia, insomnia, Huntington's, epilepsies, Alzheimer's and Parkinson's diseases. The Company is involved in the development of new and improved drugs for the treatment of psychiatric and neurological disorders. H. Lundbeck A/S is headquartered in Copenhagen, Denmark.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $434.939B 18.10
Roche Holding AG (RHHBY) Switzerland $319.781B 0.00
Pfizer (PFE) United States $249.329B 14.16
Novo Nordisk (NVO) Denmark $241.084B 33.46
Eli Lilly (LLY) United States $221.573B 28.77
AbbVie (ABBV) United States $190.996B 9.15
Novartis AG (NVS) Switzerland $188.736B 14.02
Merck (MRK) United States $182.183B 12.47
AstraZeneca (AZN) United Kingdom $175.360B 24.93
Sanofi (SNY) $121.515B 13.39
GlaxoSmithKline (GSK) United Kingdom $105.307B 13.21
Bayer (BAYRY) Germany $52.972B 7.13
Innoviva (INVA) United States $1.059B 5.69